These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8603345)

  • 41. Waldenström's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21).
    Johansson B; Waldenström J; Hasselblom S; Mitelman F
    Leukemia; 1995 Jul; 9(7):1136-8. PubMed ID: 7630185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant hematopoietic cell lines: in vitro models for the study of Waldenström's macroglobulinemia.
    Drexler HG; MacLeod RA
    Leuk Res; 2008 Nov; 32(11):1669-73. PubMed ID: 18533260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients.
    Xiong W; Wang T; Yu Y; Jiao Y; Chen J; Wang Y; Li C; Lyu R; Wang Q; Liu W; Sui W; An G; Zou D; Qiu L; Yi S
    Chin Med J (Engl); 2023 May; 136(10):1240-1242. PubMed ID: 37057735
    [No Abstract]   [Full Text] [Related]  

  • 44. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.
    Bang SM; Seo JW; Park KU; Kim SJ; Kim K; Kim SH; Cho SR; Kim HC; Song J; Kim JS; Kim KH; Lee JH; Lee JJ; Shin MG; Suh C; Chi HS; Oh DY; Won JH; Kim HJ; Yoon SS; Lee DS;
    Cancer Genet Cytogenet; 2010 Mar; 197(2):117-21. PubMed ID: 20193844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology.
    Sacco A; Issa GC; Zhang Y; Liu Y; Maiso P; Ghobrial IM; Roccaro AM
    J Hematol Oncol; 2010 Oct; 3():38. PubMed ID: 20929526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Myeloma, waldenström's disease and gamma globulin Gm and Inv groups].
    Ropartz C; Rivat L; Rousseau PY; Fine JM
    Rev Fr Etud Clin Biol; 1965 May; 10(5):507-13. PubMed ID: 4157918
    [No Abstract]   [Full Text] [Related]  

  • 47. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
    Ramont L; Ngoc PT; Pignon B; Maquart FX
    Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
    Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
    Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromosomal abnormalities in human neoplasia.
    Sandberg AA; Hossfeld DK
    Annu Rev Med; 1970; 21():379-408. PubMed ID: 4247449
    [No Abstract]   [Full Text] [Related]  

  • 50. IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.
    Zarrabi MH; Stark RS; Kane P; Dannaher CL; Chandor S
    Am J Clin Pathol; 1981 Jan; 75(1):1-10. PubMed ID: 6779622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chromosome studies in malignant diseases of the lymphoplasmoreticular system with special reference to paraproteinemias].
    Siebner H
    Arztl Forsch; 1967 Oct; 21(10):359-81. PubMed ID: 4969911
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetics and cytogenetics of Waldenstrom's macroglobulinemia.
    Schop RF; Fonseca R
    Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
    Kraj M; Maj S; Rostkowska J
    Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chromosomal and cytochemical aspects of Waldenström's disease].
    Broustet A; Veyret V; Moretti G
    Ann Biol Clin (Paris); 1968; 26(1):17-46. PubMed ID: 4172316
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on complement system in multiple myeloma and Waldenström's macroglobulinemia--specific patterns and their clinical significance (author's transl)].
    Kuribayashi K
    Rinsho Ketsueki; 1979 Oct; 20(10):1306-13. PubMed ID: 120451
    [No Abstract]   [Full Text] [Related]  

  • 57. The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia.
    van Furth R; Schuit HR; Hijmans W
    Br J Haematol; 1966 Mar; 12(2):202-11. PubMed ID: 4956762
    [No Abstract]   [Full Text] [Related]  

  • 58. Monoclonal macroglobulinemia with osteolytic lesions: a case report and review of the literature.
    Leb L; Grimes ET; Balogh K; Merritt JA
    Cancer; 1977 Jan; 39(1):227-31. PubMed ID: 401675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Specificity of the chromosomal anomaly of Waldenström's macroglobulinemia].
    Bottura C
    AMB Rev Assoc Med Bras; 1970 Apr; 16(4):119-20. PubMed ID: 4996173
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of cell lines for the study of Waldenström's macroglobulinemia.
    Gertz M; Ansell S
    Leuk Res; 2008 Nov; 32(11):1648-9. PubMed ID: 18533257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.